SCHEMBL23286

SCHEMBL23286

CCCNC([NH])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42512 0.83
SCHEMBL294158 0.81
SCHEMBL7305201 0.79 EPHX1 (0.67)
SCHEMBL4811184 0.79 EPHX1 (0.67)
SCHEMBL7300285 0.79 EPHX1 (0.67)
SCHEMBL8930393 0.79 EPHX1 (0.67)
SCHEMBL10702251 0.79 EPHX1 (0.67)
SCHEMBL7472317 0.79 EPHX1 (0.67)
SCHEMBL3842001 0.79 EPHX1 (0.67)
SCHEMBL8355975 0.79 EPHX1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230390408-A1 LINKER COMPOUNDS COMPRISING AMIDE BONDS MPEG LA, L.L.C. 2023-12-07 US claimed
CN-113717156-B EGFR inhibitor, preparation method and application thereof 南京红云生物科技有限公司 2023-05-09 CN claimed
CN-115916759-A Substituted quinazoline compound, preparation method, pharmaceutical composition and application thereof 南京红云生物科技有限公司 2023-04-04 CN claimed
CN-115697996-A Alkenyl pyrimidine compound, preparation method and application thereof 南京红云生物科技有限公司 2023-02-03 CN claimed
CN-114728009-A Preventing or treating diseases and disorders associated with tissue damage 李晓祥 2022-07-08 CN claimed
WO-2021254464-A1 SUBSTITUTED QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 南京红云生物科技有限公司 2021-12-23 WO claimed
WO-2021238827-A1 EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF 南京红云生物科技有限公司 2021-12-02 WO claimed
CN-113717156-A EGFR inhibitor, preparation method and application thereof 南京红云生物科技有限公司 2021-11-30 CN claimed
CN-109575045-B Thienopyrimidine compound, preparation method thereof, medicinal composition and application thereof 南京红云生物科技有限公司 2021-02-12 CN claimed
EP-3241829-B1 HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES BAYER CROPSCIENCE AG (DE) 2020-12-23 EP claimed
WO-1994011379-A1 HETEROCYCLIC COMPOUNDS AS ANGIOTENSIN II ANTAGONISTS ZENECA LIMITED (GB) 1994-05-26 WO claimed
US-5294620-A Hypotensive agents or compounds for cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-03-15 US claimed
WO-1994003453-A1 PYRAZOLOPYRIDINE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS ZENECA LIMITED (GB) 1994-02-17 WO claimed
US-5217976-A Hypotensive agents, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-06-08 US claimed
US-5198439-A Hypotensive agents, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-03-30 US claimed
EP-0516392-A2 Naphthyridine derivatives as angiotensin II inhibitors ZENECA LIMITED (GB) 1992-12-02 EP claimed
EP-0511791-A2 Pyrrolopyridine derivatives as Angiotensin inhibitors ZENECA LIMITED (GB) 1992-11-04 EP claimed
EP-0453210-A2 Pyridine derivatives ZENECA LIMITED (GB) 1991-10-23 EP claimed
US-4981864-A ANTICOAGULANTS BOEHRINGER MANNEHIM GMBH (DE) 1991-01-01 US claimed
EP-0209707-A2 2-Aryl imidazoles, pharmaceutical compositions containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1987-01-28 EP claimed